375 related articles for article (PubMed ID: 36304724)
1. Harnessing DNA for immunotherapy: Cancer, infectious diseases, and beyond.
Wang Y; Chen-Mayfield TJ; Li Z; Younis MH; Cai W; Hu Q
Adv Funct Mater; 2022 Sep; 32(37):. PubMed ID: 36304724
[TBL] [Abstract][Full Text] [Related]
2. Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.
Iurescia S; Fioretti D; Rinaldi M
Recent Pat Anticancer Drug Discov; 2018; 13(1):2-17. PubMed ID: 29086701
[TBL] [Abstract][Full Text] [Related]
3. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Vaccines for Cancer Immunotherapy.
Wang J; Mamuti M; Wang H
ACS Biomater Sci Eng; 2020 Nov; 6(11):6036-6052. PubMed ID: 33449675
[TBL] [Abstract][Full Text] [Related]
5. Emerging vaccine nanotechnology: From defense against infection to sniping cancer.
Feng C; Li Y; Ferdows BE; Patel DN; Ouyang J; Tang Z; Kong N; Chen E; Tao W
Acta Pharm Sin B; 2022 May; 12(5):2206-2223. PubMed ID: 35013704
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccine for cancer immunotherapy.
Yang B; Jeang J; Yang A; Wu TC; Hung CF
Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial DNA sensing by STING signaling participates in inflammation, cancer and beyond.
Liu S; Feng M; Guan W
Int J Cancer; 2016 Aug; 139(4):736-41. PubMed ID: 26939583
[TBL] [Abstract][Full Text] [Related]
8. Nanodelivery of STING agonists against cancer and infectious diseases.
Zhou J; Ventura CJ; Fang RH; Zhang L
Mol Aspects Med; 2022 Feb; 83():101007. PubMed ID: 34353637
[TBL] [Abstract][Full Text] [Related]
9. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Dendrimers for cancer immunotherapy: Avidity-based drug delivery vehicles for effective anti-tumor immune response.
Rawding PA; Bu J; Wang J; Kim DW; Drelich AJ; Kim Y; Hong S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1752. PubMed ID: 34414690
[TBL] [Abstract][Full Text] [Related]
12. Emerging Role of Exosomes in Tuberculosis: From Immunity Regulations to Vaccine and Immunotherapy.
Sun YF; Pi J; Xu JF
Front Immunol; 2021; 12():628973. PubMed ID: 33868247
[TBL] [Abstract][Full Text] [Related]
13. Nucleic Acid Immunity.
Hartmann G
Adv Immunol; 2017; 133():121-169. PubMed ID: 28215278
[TBL] [Abstract][Full Text] [Related]
14. Nucleic acid and oligonucleotide delivery for activating innate immunity in cancer immunotherapy.
Meng F; Wang J; Yeo Y
J Control Release; 2022 May; 345():586-600. PubMed ID: 35351528
[TBL] [Abstract][Full Text] [Related]
15. Rationale for stimulator of interferon genes-targeted cancer immunotherapy.
Rivera Vargas T; Benoit-Lizon I; Apetoh L
Eur J Cancer; 2017 Apr; 75():86-97. PubMed ID: 28219022
[TBL] [Abstract][Full Text] [Related]
16. A General Biomineralization Strategy to Synthesize Autologous Cancer Vaccines with cGAS-STING Activating Capacity for Postsurgical Immunotherapy.
Li Q; Dong Z; Cao Z; Lei H; Wang C; Hao Y; Feng L; Liu Z
ACS Nano; 2023 Jun; 17(11):10496-10510. PubMed ID: 37184402
[TBL] [Abstract][Full Text] [Related]
17. Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants.
Dubensky TW; Kanne DB; Leong ML
Ther Adv Vaccines; 2013 Nov; 1(4):131-43. PubMed ID: 24757520
[TBL] [Abstract][Full Text] [Related]
18. Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies.
Iurescia S; Fioretti D; Rinaldi M
Front Immunol; 2018; 9():711. PubMed ID: 29686682
[TBL] [Abstract][Full Text] [Related]
19. The future of cancer immunotherapy: DNA vaccines leading the way.
Pandya A; Shah Y; Kothari N; Postwala H; Shah A; Parekh P; Chorawala MR
Med Oncol; 2023 Jun; 40(7):200. PubMed ID: 37294501
[TBL] [Abstract][Full Text] [Related]
20. Nucleic acid vaccination strategies against infectious diseases.
Marć MA; Domínguez-Álvarez E; Gamazo C
Expert Opin Drug Deliv; 2015; 12(12):1851-65. PubMed ID: 26365499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
